Exodus Point Capital Management, LP Atri Cure, Inc. Transaction History
Exodus Point Capital Management, LP
- $14.7 Billion
- Q2 2024
A detailed history of Exodus Point Capital Management, LP transactions in Atri Cure, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 67,021 shares of ATRC stock, worth $1.86 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
67,021
Previous 61,517
8.95%
Holding current value
$1.86 Million
Previous $1.87 Million
18.44%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding ATRC
# of Institutions
209Shares Held
49.3MCall Options Held
111KPut Options Held
23.8K-
Vanguard Group Inc Valley Forge, PA4.62MShares$128 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$128 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY4.2MShares$116 Million0.03% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.67MShares$74.1 Million0.39% of portfolio
-
Macquarie Group LTD Australia, C32MShares$55.3 Million0.05% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.29B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...